MedPath

Clinically node negative breast cancer patients undergoing breast conserving therapy: Sentinel lymph node procedure versus follow-up (BOOG 2013-08).

Recruiting
Conditions
breast neoplasms
breast cancer
sentinel lymph node biopsy
breast conserving therapy.
Registration Number
NL-OMON28389
Lead Sponsor
KWF, CZ, ZonMw
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
1644
Inclusion Criteria

1. Female

2. Aged 18 years or older

Exclusion Criteria

1. Clinically node positive pre-operative

2. Bilateral breast cancer

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Regional recurrence rate after 5- and 10 years of follow-up.
Secondary Outcome Measures
NameTimeMethod
Distant-disease free survival, overall survival, delayed axillary lymph node dissections, axillary morbidity, quality of life, local recurrence, contralateral breast cancer, and percentage difference in administered (neo)adjuvant systemic therapy after 5- and 10 years of follow-up.
© Copyright 2025. All Rights Reserved by MedPath